Share Email Print

Proceedings Paper

Preliminary results from multicenter clinical trials for detection of cervical squamous intraepithelial lesions using a novel full-field evoked-tissue-flourescence-based imaging instrument
Author(s): Anupam K. Dattamajumdar; D. Wells; Julie R. Parnell; Dipankur Ganguly; Thomas C. Wright
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

We report preliminary results from a multi-center trial of evaluating the performance of a novel, full-field multi-spectral tissue fluorescence imaging system (CerviscanTM) designed to detect cervical squamous intraepithelial lesions. Spectral data from multiple regions of 48 patients enrolled from clinical performance sites in the US and Canada are included in this preliminary analysis. This includes 30 women used for the training set and 18 used for the testing set. In the testing set, 37/43 SIL and 70/80 NonSIL regions were correctly identified for a sensitivity of 86% and specificity of 87.5%. CerviscanTM locates cervical precancerous lesions with high sensitivity and specificity and has the potential to permit 'see and treat' patient management.

Paper Details

Date Published: 31 October 2001
PDF: 2 pages
Proc. SPIE 4432, Diagnostic Optical Spectroscopy in Biomedicine, (31 October 2001); doi: 10.1117/12.447157
Show Author Affiliations
Anupam K. Dattamajumdar, LifeSpex, Inc. (United States)
D. Wells, LifeSpex, Inc. (United States)
Julie R. Parnell, LifeSpex, Inc. (United States)
Dipankur Ganguly, LifeSpex, Inc. (United States)
Thomas C. Wright, Columbia Univ. (United States)

Published in SPIE Proceedings Vol. 4432:
Diagnostic Optical Spectroscopy in Biomedicine
Theodore G. Papazoglou; Georges A. Wagnieres, Editor(s)

© SPIE. Terms of Use
Back to Top